| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/16/2011 | EP2283816A1 Melt-extruded orally administrable opioid formulations |
| 02/16/2011 | EP2283815A1 Propellant-free non polar buccal spray of a sedative |
| 02/16/2011 | EP2283814A1 Polar buccal spray of a sedative |
| 02/16/2011 | EP2283813A1 Propellant-free polar buccal spray of a sedative |
| 02/16/2011 | EP2283811A1 Solid pharmaceutical composition comprising donepezil hydrochloride |
| 02/16/2011 | EP2283807A1 Moisturizing agent |
| 02/16/2011 | EP2283144A2 Enzymatic synthesis of sphingolipids |
| 02/16/2011 | EP2283143A2 Enzymatic synthesis of sphingolipids |
| 02/16/2011 | EP2283133A2 Compositions and use of epas1 inhibitors |
| 02/16/2011 | EP2283130A1 DISPERSINBtm, 5-FLUOROURACIL, DEOXYRIBONUCLEASE I AND PROTEINASE K-BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF |
| 02/16/2011 | EP2283045A1 Separation of polysaccharides by charge density gradient |
| 02/16/2011 | EP2283024A1 4-aryl-2-anilino-pyrimidines as plk kinase inhibitors |
| 02/16/2011 | EP2283023A2 Bryostatin analogues and methods of making and using thereof |
| 02/16/2011 | EP2283022A1 Furo ý3, 2-b¨pyrr0l-3-0nes as cathepsin s inhibitors |
| 02/16/2011 | EP2283020A1 Substituted imidazopyr-and imidazotri-azines |
| 02/16/2011 | EP2283019A1 Gpr119 receptor agonists |
| 02/16/2011 | EP2283018A1 Hepatitis c virus inhibitors |
| 02/16/2011 | EP2283017A1 Fused pyrimidineone compounds as trpv3 modulators |
| 02/16/2011 | EP2283016A1 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
| 02/16/2011 | EP2283014A1 Polymorphs of hydrochloride salt o5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyridoý2,3-b¨indole-7-carboxamideand methods of use therefor |
| 02/16/2011 | EP2283013A1 Inhibitors of phosphatidylinositol 3-kinase |
| 02/16/2011 | EP2283011A1 2-phenyl-4-cyclopropyl-pyrimidine derivatives |
| 02/16/2011 | EP2283009A1 Inhibitors of jnk |
| 02/16/2011 | EP2283008A2 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 02/16/2011 | EP2283007A2 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 02/16/2011 | EP2283005A2 Cisatracurium derivatives, preparation and uses thereof |
| 02/16/2011 | EP2283004A1 Amido-thiophene compounds and their use |
| 02/16/2011 | EP2283002A2 Novel inhibitors of hepatitis c virus replication |
| 02/16/2011 | EP2283000A2 3- or 4-substituted piperidine compounds |
| 02/16/2011 | EP2282999A1 Amino-quinoxaline and amino-quinoline compounds for use as adenosine a2a receptor antagonists |
| 02/16/2011 | EP2282997A2 4-methyl-4,5-dihydro-1h-pyrazole-3-carboxamide useful as cannabinoid cb1 neutral antagonist |
| 02/16/2011 | EP2282996A1 Tetrahydroisoquinolines as antimalarial agents |
| 02/16/2011 | EP2282995A1 Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors |
| 02/16/2011 | EP2282994A1 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor |
| 02/16/2011 | EP2282982A1 Novel [f-18]-labelled l-glutamic acid- and l-glutamine derivatives (i), use thereof and method for their production |
| 02/16/2011 | EP2282981A1 {f-19} -labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them |
| 02/16/2011 | EP2282777A1 Topical combinations comprising an antimycotic agent and an antiviral agent |
| 02/16/2011 | EP2282762A2 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 02/16/2011 | EP2282759A2 Use of nucleic acids with reduced pressure therapy for treating wounds |
| 02/16/2011 | EP2282756A1 Methods of diagnosing, preventing and treating bone mass diseases |
| 02/16/2011 | EP2282752A1 Saponin extract from saponaria spp and uses thereof |
| 02/16/2011 | EP2282744A1 Oligomeric compounds comprising tricyclic nucleosides and methods for their use |
| 02/16/2011 | EP2282743A1 Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair |
| 02/16/2011 | EP2282742A1 Inhibitors of fatty acid amide hydrolase |
| 02/16/2011 | EP2282741A2 Treating eosinophilic esophagitis |
| 02/16/2011 | EP2282740A1 Antifolate compositions |
| 02/16/2011 | EP2282739A2 Sequential administration of chemotherapeutic agents for treatment of cancer |
| 02/16/2011 | EP2282738A2 Promoting axon regeneration in the adult cns through control of protein translation |
| 02/16/2011 | EP2282737A2 Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone |
| 02/16/2011 | EP2282736A2 Tetrazole compounds for reducing uric acid |
| 02/16/2011 | EP2282735A1 Compounds, compositions and methods for making the same |
| 02/16/2011 | EP2282734A2 Method for protecting humans against superficial vasodilator flush syndrome |
| 02/16/2011 | EP2282733A2 Protection of normal cells |
| 02/16/2011 | EP2282732A2 Use of olive oil extract to control skin aging |
| 02/16/2011 | EP2282731A1 Combination therapy for acne vulgaris comprising adapalene 0.3% gel with clindamycin/benzoyl peroxide gel |
| 02/16/2011 | EP2282730A1 Methods of treating fungal infections |
| 02/16/2011 | EP2282729A1 Methods and compositions for treating inflammation and inflammation-related pathologies |
| 02/16/2011 | EP2282724A2 Modified drugs for use in liposomal nanoparticles |
| 02/16/2011 | EP2282721A2 Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant |
| 02/16/2011 | EP2282719A2 Compositions and methods for treating multiple sclerosis |
| 02/16/2011 | EP2173196B1 Use of probiotics and fibers for diarrhoea |
| 02/16/2011 | EP2155729B1 Prolinamide-tetrazole derivatives as nk3 receptor antagonists |
| 02/16/2011 | EP2111401B1 4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino]-3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer |
| 02/16/2011 | EP2061433B1 Compositions for enhancing transport through mucus |
| 02/16/2011 | EP2046762B1 Triazolyl phenyl benzenesulfonamides |
| 02/16/2011 | EP2010518B1 Azabicyclo [3. 1. o] hexane derivatives as modulators of dopamine d3 receptors |
| 02/16/2011 | EP1940478B1 Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate |
| 02/16/2011 | EP1919469B1 Process for preparing an angiotensin ii receptor antagonist |
| 02/16/2011 | EP1890558B1 Food products containing laminarin |
| 02/16/2011 | EP1827425B1 Use of ppar agonists for the treatment of congestive heart failure |
| 02/16/2011 | EP1781708B1 Materials and methods for immune system stimulation |
| 02/16/2011 | EP1781260B9 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 02/16/2011 | EP1771422B1 Quinazolinone derivatives as parp inhibitors |
| 02/16/2011 | EP1766010B1 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| 02/16/2011 | EP1723151B1 Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines |
| 02/16/2011 | EP1708686B1 Generally linear effervescent oral fentanyl dosage form and methods of administering |
| 02/16/2011 | EP1699434B1 Process for preparing a medicament |
| 02/16/2011 | EP1664035B1 2,4 di(hetero)-arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors |
| 02/16/2011 | EP1663105B1 Cycloalkyl heterocycles for treating hepatitis c virus |
| 02/16/2011 | EP1615866B1 Indene derivatives as pharmaceutical agents |
| 02/16/2011 | EP1599211B1 Use isoharmnetin for treating depressive states and depression |
| 02/16/2011 | EP1532279B1 Method, composition and kit for antigenic binding of norwalk-like viruses |
| 02/16/2011 | EP1455794B1 ClC-2 CHANNEL OPENER FOR TREATING GASTRIC OR BOWEL ULCER |
| 02/16/2011 | EP1424080B1 Gnrh agonist combination drugs |
| 02/16/2011 | EP1379498B1 Sulphones which modulate the action of gamma secretase |
| 02/16/2011 | EP1373207B1 Novel amlodipine camsylate and method for preparing thereof |
| 02/16/2011 | EP1309568B1 [(quinazolin-4-yl)piperazin-4-yl]thiocarboxamide compounds as inhibitors of the phosphorylation of a PDGF receptor |
| 02/16/2011 | EP1222265B1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
| 02/16/2011 | CN1994385B Externally applied Chinese medicinal effervescence tablet for fumigating and washing to treat external piles and anal fissure and method for preparing same |
| 02/16/2011 | CN1989113B Quinazoline derivatives |
| 02/16/2011 | CN1972926B Indole derivatives as histamine receptor antagonists |
| 02/16/2011 | CN1960727B Naphthalene derivatives useful as histamine-3-receptor ligands |
| 02/16/2011 | CN1935191B External ointment for treating facioplegia and its production method |
| 02/16/2011 | CN1919247B Chinese medicine for treating cardiovascular and cerebrovascular disease |
| 02/16/2011 | CN1872077B Medicine for treating cardiac insufficiency |
| 02/16/2011 | CN1850804B Optical-purity meptazinol orits salts, and preparing method |
| 02/16/2011 | CN1846456B Communication system for wireless microphone |
| 02/16/2011 | CN1814194B Chinese-western medicine composition for treating infant's common cold and preparation method thereof |
| 02/16/2011 | CN101978060A Novel fer -like protein, pharmaceutical compositions containing it and method for its use |
| 02/16/2011 | CN101978059A Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |